• news.cision.com/
  • Medivir/
  • Lipsovir® prevents cold sores. Phase III clinical trial results presented at a press conference today
English

Lipsovir® prevents cold sores. Phase III clinical trial results presented at a press conference today

Report this content

At the press conference today the results from the clinical phase III trial for Lipsovir® were presented. The presentation is now available on Medivirs’ web-site:
www.medivir.se


For additional information, please contact:
Rein Piir, Medivir’s CFO & VP Investor Relations.
+46 8 5468 3123 or +46 708 537292

Subscribe

Documents & Links